̽ѡ

Penny Nymark

Penny Nymark

Research Specialist
Visiting address: Nobels väg 13, 17177 Stockholm
Postal address: C6 Institutet för miljömedicin, C6 Ledningskansliet, 171 77 Stockholm
Part of:

About me

  • I am a researcher at the Institute of Environmental Medicine at Karolinska
    Institutet with a background in genetics, cancer and toxicology. In recent
    years, my main focus has turned towards development of Adverse Outcome
    Pathways (AOPs) and New Approach Methodologies (NAMs), as well as their
    application in risk assessment and in safe and sustainable development of new
    technologies. Coupled to this focus, I also have a broad interest in making
    data Findable, Accessible, Interoperable and Reusable (FAIR). In addition to
    research, I function as coordinator within the Swedish platform for
    Nanosafety, SweNanoSafe [1], where I focus on communication, education and
    sustainability (e.g. Safe and Sustainable by Design, SSbD) aspects within
    nanosafety.

    *Ongoing projects and involvements:*
    Toward risk assessment without animals: Development of Adverse Outcome
    Pathways for lung cancer [2]

    PARC [3]- European Partnership for the Assessment of Risks from Chemicals

    HARMLESS [4] - Advanced high aspect ratio multicomponent materials: towards
    comprehensive intelligent testing and safe by design strategies

    *Selected previous projects and involvements:*
    Gov4Nano [5] - Implementation of Risk Governance: meeting the needs of
    nanotechnology

    eNanoMapper [6] - A Database and Ontology Framework for Nanomaterials Design
    and Safety Assessment

    NANoREG [7] - A common European approach to the regulatory testing of
    nanomaterials

    NANOSOLUTIONS [8] - Biological Foundation for the Safety Classification of
    Engineered Nanomaterials (ENM): Systems Biology Approaches to Understand
    Interactions of ENM with Living Organisms and the Environment

    NanoReg2 [9] - Development and implementation of Grouping and Safe-by-Design
    approaches within regulatory frameworks

    caLIBRAte [10] - Performance testing, calibration and implementation of a
    next generation system-of-systems Risk Governance Framework for nanomaterials

    PATROLS [11] – Physiologically Anchored Tools for Realistic nanOmateriaL
    hazard aSsessment

    NanoSolveIT [12] – Innovative Nanoinformatics models and tools: towards a
    Solid, verified and Integrated Approach to Predictive (eco)Toxicology

    miRNAno [13] - Toxicogenomic studies on engineered carbon nanomaterials
    Application of the Adverse Outcome Pathway concept and bioinformatics for
    mechanistic understanding of COVID-19 [14]

    [1]
    [2] /en/imm/toward-risk-assessment-without-animals-development-of-adverse-outcome-pathways-for-lung-cancer
    [3]
    [4]
    [5]
    [6]
    [7]
    [8]
    [9]
    [10]
    [11]
    [12]
    [13]
    [14] /en/imm/application-of-the-adverse-outcome-pathway-concept-and-bioinformatics-for-mechanistic

Research

  • *Selected publications:*

    Wittwehr C, Clerbaux LA, Edwards S, Angrish M, Mortensen H, Carusi A,
    Gromelski M, Lekka E, Virvilis V, Martens M, Bonino da Silva Santos
    LO, *Nymark P. *Why adverse outcome pathways need to be FAIR. [1] ALTEX.
    2023 Aug 1. doi: 10.14573/altex.2307131. Online ahead of print.

    Dumit, V. I., Ammar, A., Bakker, M. I., Bañares, M. A., Bossa, C., Costa,
    A., Cowie, H., Drobne, D., Exner, T. E., Farcal, L., Friedrichs, S., Furxhi,
    I., Grafström, R., Haase, A., Himly, M., Jeliazkova, N., Lynch, I., Maier,
    D., Noorlander, C. W., ... *Nymark, P*. (2023). From principles to reality.
    FAIR implementation in the nanosafety community. [2] /Nano Today/, /51/,
    [101923]. doi: 10.1016/j.nantod.2023.101923

    Grafström R, Haase A, Kohonen P, Jeliazkova N, *Nymark P. *Reply to:
    Prospects and challenges for FAIR toxicogenomics data. [3] Nat Nanotechnol.
    2021 Dec 23. doi: 10.1038/s41565-021-01050-8. Online ahead of print.

    Lynch I, *Nymark P*, Doganis P, Gulumian M, Yoon TH, Martinez DST, Afantitis
    A. Methods, models, mechanisms and metadata: Introducing the Nanotoxicology
    collection at F1000Research. [4] F1000Res. 2021 Nov 24
  • 10:1196. doi:
    10.12688/f1000research.75113.1. eCollection 2021.

    Bossa C, Andreoli C, Bakker M, Barone F, De Angelis I, Jeliazkova N, *Nymark
    P*, Battistelli CL. FAIRification of nanosafety data to improve
    applicability of (Q)SAR approaches: A case study on /in vitro/ Comet assay
    genotoxicity data. [5] Comput Toxicol. 2021 Nov
  • 20:100190. doi:
    10.1016/j.comtox.2021.100190.

    Jeliazkova N, Apostolova MD, Andreoli C, Barone F, Barrick A, Battistelli C,
    Bossa C, Botea-Petcu A, Châtel A, De Angelis I, Dusinska M, El Yamani N,
    Gheorghe D, Giusti A, Gómez-Fernández P, Grafström R, Gromelski M,
    Jacobsen NR, Jeliazkov V, Jensen KA, Kochev N, Kohonen P, Manier N, Mariussen
    E, Mech A, Navas JM, Paskaleva V, Precupas A, Puzyn T, Rasmussen K, Ritchie
    P, Llopis IR, Rundén-Pran E, Sandu R, Shandilya N, Tanasescu S, Haase A,
    *Nymark P.* Towards FAIR nanosafety data. [6]Nat Nanotechnol. 2021 May 20.
    doi: 10.1038/s41565-021-00911-6.

    *Nymark P*, Karlsson HL, Halappanavar S, Vogel U. Adverse Outcome Pathway
    development for assessment of lung carcinogenicity by nanoparticles [7].
    Frontiers in Toxicology, 29 April 2021. doi: 10.3389/ftox.2021.653386

    *Nymark P, * Sachana M, Batista-Leite S, Sund J, Krebs C.E., Sullivan K,
    Edwards S, Viviani L, Willett K, Landesmann B, Wittwehr C. Systematic
    Organization of COVID-19 Data Supported by the Adverse Outcome Pathway
    Framework [8]. Frontiers in Public Health, 19 May 2021, doi:
    10.3389/fpubh.2021.638605

    Halappanavar S, van den Brule S, * Nymark P*, Gaté L, Seidel C, Valentino S,
    Zhernovkov V, Høgh Danielsen P, De Vizcaya A, Wolff H, Stöger T, Boyadziev
    A, Poulsen SS, Sørli JB, Vogel U. Adverse outcome pathways as a tool for the
    design of testing strategies to support the safety assessment of emerging
    advanced materials at the nanoscale. [9] Part Fibre Toxicol. 2020 May
    25
  • 17(1):16. doi: 10.1186/s12989-020-00344-4.

    *Nymark P*, Bakker M, Dekkers S, Franken R, Fransman W, García-Bilbao A,
    Greco D, Gulumian M, Hadrup N, Halappanavar S, Hongisto V, Hougaard KS,
    Jensen KA, Kohonen P, Koivisto AJ, Dal Maso M, Oosterwijk T, Poikkimäki M,
    Rodriguez-Llopis I, Stierum R, Sørli JB, Grafström R. Toward Rigorous
    Materials Production: New Approach Methodologies Have Extensive Potential to
    Improve Current Safety Assessment Practices. [10]Small. 2020
    Feb
  • 16(6):e1904749. doi: 10.1002/smll.201904749. Epub 2020 Jan 8.

    Soeteman-Hernandez LG, Apostolova MD, Bekker C, Dekkers S, Grafström RC,
    Groenewold M, Handzhiyski Y, Herbeck-Engel P, Hoehener K, Karagkiozaki V,
    Kelly S, Kraegeloh A, Logothetidis S, Micheletti C, *Nymark P*, Oomen A,
    Oosterwijk T, Rodríguez-LLopis I, Sabella S, Sanchez Jiménez A, Sips A,
    Suarez-Merino B, Tavernaro I, van Engelen J, Wijnhoven SWP, Noorlander CW.
    Safe innovation approach: Towards an agile system for dealing with
    innovations. [11] Materials Today Communications, Volume 20, 2019, 100548,
    ISSN 2352-4928, doi: 10.1016/j.mtcomm.2019

    Giusti A, Atluri R, Tsekovska R, Gajewicz A, Apostolova MD, Battistelli CL,
    Bleeker EAJ, Bossa C, Bouillard j, Dusinska M, Gómez-Fernández P,
    Grafström R, Gromelski M, Handzhiyski Y, Jacobsen NR, Jantunen P, Jensen KA,
    Mech A, Navas JM, *Nymark P*, Oomen AG, Puzyn T, Rasmussen K, Riebeling C,
    Rodriguez-Llopis I, Sabella S, Riego Sintes J, Suarez-Merino B, Tanasescu S,
    Wallin H, Haase A. Nanomaterial grouping: Existing approaches and future
    recommendations [12]. NanoImpact, Volume 16, 2019, 100182, ISSN 2452-0748,
    doi: 10.1016/j.impact.2019.100182

    *Nymark P*, Kohonen P, Hongisto V, Grafström RC. Toxic and Genomic
    Influences of Inhaled Nanomaterials as a Basis for Predicting Adverse
    Outcome. [13]Ann Am Thorac Soc. 2018 Apr
  • 15(Suppl 2):S91-S97. doi:
    10.1513/AnnalsATS.201706-478MG.

    *Nymark P*, Rieswijk L, Ehrhart F, Jeliazkova N, Tsiliki G, Sarimveis H,
    Evelo CT, Hongisto V, Kohonen P, Willighagen E, Grafström RC. A Data Fusion
    Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions.
    [14]Toxicol Sci. 2018 Mar 1
  • 162(1):264-275. doi: 10.1093/toxsci/kfx252.

    *Nymark P*, Wijshoff P, Cavill R, van Herwijnen M, Coonen ML, Claessen S,
    Catalán J, Norppa H, Kleinjans JC, Briedé JJ. Extensive temporal
    transcriptome and microRNA analyses identify molecular mechanisms underlying
    mitochondrial dysfunction induced by multi-walled carbon nanotubes in human
    lung cells. [15] Nanotoxicology, 2015. 9(5): p. 624-635. doi:
    10.3109/17435390.2015.1017022

    *Nymark P*, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K, Kettunen E,
    Anttila S, Knuutila S. Integrative Analysis of microRNA, mRNA and aCGH Data
    Reveals Asbestos-Related Changes in Non-Small Cell Lung Cancer. [16] Genes,
    Chromosom. Cancer, 2011. 50(8):585-97. doi: 10.1002/gcc.20880

    *Nymark P*, Wikman H, Hienonen-Kempas T, Anttila S. Molecular and genetic
    changes in asbestos-related lung cancer [17]. Cancer Lett. 2008. 265(1):1-15.
    Doi: 10.1016/j.canlet.2008.02.043

    [1]
    [2]
    [3]
    [4]
    [5]
    [6]
    [7]
    [8]
    [9]
    [10]
    [11]
    [12]
    [13]
    [14]
    [15]
    [16]
    [17]

Teaching

  • *Teaching:*
    I am course leader for the PhD course /Human Cell Culture. Methods and
    Applications/. (code 3127). I also lead course modules in the Master Program
    in Toxicology, including on bioinformatics and omics, as well as a workshop
    on toxicological high-throughput screening assays and data (ToxCast
    workshop). Furthermore, I provide a number of lectures both at KI and other
    universities and external courses in the areas of human cell culture methods,
    alternative (3R) methods, toxicogenomics and systems toxicology,
    bioinformatics, high-throughput screening approaches, data management (FAIR
    principles), Adverse Outcome Pathways (AOPs) and Safe and Sustainable by
    Design (SSbD).

Articles

  • Article: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2024;25:105-126
    Cassee FR; Bleeker EAJ; Durand C; Exner T; Falk A; Friedrichs S; Heunisch E; Himly M; Hofer S; Hofstaetter N; Hristozov D; Nymark P; Pohl A; Soeteman-Hernandez LG; Suarez-Merino B; Valsami-Jones E; Groenewold M
  • Article: ADVANCED SCIENCE. 2024;11(9):e2306268
    Dumit VI; Liu Y-C; Bahl A; Kohonen P; Grafstrom RC; Nymark P; Mueller-Graf C; Haase A; Pink M
  • Article: ALTEX. 2024;41(1):50-56
    Wittwehr C; Clerbaux L-A; Edwards S; Angrish M; Mortensen H; Carusi A; Gromelski M; Lekka E; Virvilis V; Martens M; Santos LOBDS; Nymark P
  • Article: ALTEX. 2024;41(2):233-247
    Clerbaux L-A; Filipovska J; Nymark P; Chauhan V; Sewald K; Alb M; Sachana M; Beronius A; Amorim M-J; Wittwehr C
  • Journal article: TOXICOLOGY LETTERS. 2023;384:s105-S108
    Kumar S; ZaidKilani N; Khalid S; Slater L; Karakoltzidis A; Papaioannou N; Nymark P; Tollefsen KE; Rashwan HA; Audouze K; Kumar V
  • Article: NANO TODAY. 2023;51:101923
    Dumit VI; Ammar A; Bakker MI; Banares MA; Bossa C; Costa A; Cowie H; Drobne D; Exner TE; Farcal L; Friedrichs S; Furxhi I; Grafstroem R; Haase A; Himly M; Jeliazkova N; Lynch I; Maier D; Noorlander CW; Shin HK; Soler-Illia GJAA; Suarez-Merino B; Willighagen E; Nymark P
  • Journal article: ANNALS OF WORK EXPOSURES AND HEALTH. 2023;67(Supplement_1):i65-i66
    Jensen KA; Liguori B; Ribalta C; Shandilya N; Bakker M; Suarez-Merino B; Porcari A; Delpivo C; Bleeker E; Pohl A; Nymark P; Nowack B; Franken R; Hristozov D; Fransman W
  • Article: JOURNAL OF CHEMINFORMATICS. 2023;15(1):34
    Bahl A; Ibrahim C; Plate K; Haase A; Dengjel J; Nymark P; Dumit VI
  • Article: FRONTIERS IN TOXICOLOGY. 2023;5:1319985
    Shao G; Beronius A; Nymark P
  • Article: FRONTIERS IN TOXICOLOGY. 2023;5:1183824
    Wiklund L; Caccia S; Pipal M; Nymark P; Beronius A
  • Article: JOURNAL OF CHEMINFORMATICS. 2022;14(1):57
    van Rijn J; Afantitis A; Culha M; Dusinska M; Exner TE; Jeliazkova N; Longhin EM; Lynch I; Melagraki G; Nymark P; Papadiamantis AG; Winkler DA; Yilmaz H; Willighagen E
  • Article: NANOIMPACT. 2022;27:100402
    Krans NA; Ammar A; Nymark P; Willighagen EL; Bakker MI; Quik JTK
  • Article: FRONTIERS IN ONCOLOGY. 2022;12:849640
    Martens M; Kreidl F; Ehrhart F; Jean D; Mei M; Mortensen HM; Nash A; Nymark P; Evelo CT; Cerciello F
  • Article: ALTEX. 2022;39(2):322-335
    Clerbaux L-A; Amigo N; Amorim MJ; Bal-Price A; Leite SB; Beronius A; Bezemer GFG; Bostroem A-C; Carusi A; Coecke S; Concha R; Daskalopoulos EP; Debernardi F; Edrosa E; Edwards SW; Filipovska J; Garcia-Reyero N; Gavins FNE; Halappanavar S; Hargreaves AJ; Hogberg HT; Huynh MT; Jacobson D; Josephs-Spaulding J; Kim YJ; Kong HJ; Krebs CE; Lam A; Landesmann B; Layton AR; Lee YO; Macmillan DS; Mantovani A; Margiotta-Casaluci L; Martens M; Masereeuw R; Mayasich SA; Mei LM; Mortensen H; Munoz A; Nymark P; Ohayon E; Ojasi JM; Paini A; Parissis N; Parvatam S; Pistollato F; Sachana M; Sorli JB; Sullivan KM; Sund J; Tanabe S; Tsaioun K; Vinken M; Viviani L; Waspe J; Willett C; Wittwehr C
  • Journal article: F1000RESEARCH. 2021;10:elixir-1129
    Martens M; Stierum R; Schymanski EL; Evelo CT; Aalizadeh R; Aladjov H; Arturi K; Audouze K; Babica P; Berka K; Bessems J; Blaha L; Bolton EE; Cases M; Damalas DΕ; Dave K; Dilger M; Exner T; Geerke DP; Grafström R; Gray A; Hancock JM; Hollert H; Jeliazkova N; Jennen D; Jourdan F; Kahlem P; Klanova J; Kleinjans J; Kondic T; Kone B; Lynch I; Maran U; Cuesta SM; Ménager H; Neumann S; Nymark P; Oberacher H; Ramirez N; Remy S; Rocca-Serra P; Salek RM; Sallach B; Sansone S-A; Sanz F; Sarimveis H; Sarntivijai S; Schulze T; Slobodnik J; Spjuth O; Tedds J; Thomaidis N; Weber RJM; van Westen GJP; Wheelock CE; Williams AJ; Witters H; Zdrazil B; Županič A; Willighagen EL
  • Article: COMPUTATIONAL TOXICOLOGY. 2021;20:100190
    Bossa C; Andreoli C; Bakker M; Barone F; De Angelis I; Jeliazkova N; Nymark P; Battistelli CL
  • Article: NATURE NANOTECHNOLOGY. 2021;16(6):644-654
    Jeliazkova N; Apostolova MD; Andreoli C; Barone F; Barrick A; Battistelli C; Bossa C; Botea-Petcu A; Chatel A; De Angelis I; Dusinska M; El Yamani N; Gheorghe D; Giusti A; Gomez-Fernandez P; Grafstrom R; Gromelski M; Jacobsen NR; Jeliazkov V; Jensen KA; Kochev N; Kohonen P; Manier N; Mariussen E; Mech A; Navas JM; Paskaleva V; Precupas A; Puzyn T; Rasmussen K; Ritchie P; Llopis IR; Runden-Pran E; Sandu R; Shandilya N; Tanasescu S; Haase A; Nymark P
  • Article: NANOMATERIALS. 2021;11(3):639
    Radnik J; Kersting R; Hagenhoff B; Bennet F; Ciornii D; Nymark P; Grafstrom R; Hodoroaba V-D
  • Article: FRONTIERS IN TOXICOLOGY. 2021;3:653386
    Nymark P; Karlsson HL; Halappanavar S; Vogel U
  • Article: FRONTIERS IN PUBLIC HEALTH. 2021;9:638605
    Nymark P; Sachana M; Leite SB; Sund J; Krebs CE; Sullivan K; Edwards S; Viviani L; Willett C; Landesmann B; Wittwehr C
  • Show more

All other publications

  • Review: NATURE PROTOCOLS. 2024;19(11):3456
    Jeliazkova N; Longhin E; El Yamani N; Runden-Pran E; Moschini E; Serchi T; Vrcek IV; Burgum MJ; Doak SH; Cimpan MR; Rios-Mondragon I; Cimpan E; Battistelli CL; Bossa C; Tsekovska R; Drobne D; Novak S; Repar N; Ammar A; Nymark P; Di Battista V; Sosnowska A; Puzyn T; Kochev N; Iliev L; Jeliazkov V; Reilly K; Lynch I; Bakker M; Delpivo C; Jimenez AS; Fonseca AS; Manier N; Fernandez-Cruz ML; Rashid S; Willighagen E; Apostolova M; Dusinska M
  • Review: NANOTOXICOLOGY. 2024;18(4):373-400
    Bahl A; Halappanavar S; Wohlleben W; Nymark P; Kohonen P; Wallin H; Vogel U; Haase A
  • Conference publication: TOXICOLOGY LETTERS. 2023;384:s310-S317
    Filipovska J; Clerbaux L-A; Carusi A; Amorim M-J; Nymark P; Chauhan V; Sachana M; Beronius A; Edwards SW; Wittwehr C
  • Conference publication: TOXICOLOGY LETTERS. 2023;384:s256-S262
    Hanberg A; Dreij K; Beronius A; Karlsson H; Wincent E; Nymark P; Zilliacus J
  • Conference publication: TOXICOLOGY LETTERS. 2023;384:S105
    Kumar S; ZaidKilani N; Khalid S; Slater L; Karakoltzidis A; Papaioannou N; Nymark P; Tollefsen KE; Rashwan HA; Audouze K; Kumar V
  • Conference publication: TOXICOLOGY LETTERS. 2023;384:S310
    Filipovska J; Clerbaux L-A; Carusi A; Amorim M-J; Nymark P; Chauhan V; Sachana M; Beronius A; Edwards SW; Wittwehr C
  • Editorial comment: NATURE NANOTECHNOLOGY. 2022;17(1):19-20
    Grafstrom R; Haase A; Kohonen P; Jeliazkova N; Nymark P
  • Conference publication: TOXICOLOGY LETTERS. 2021;350:S60
    Conway GE; Llewellyn SV; Nymark P; Vogel UB; Halappanavar S; Jenkins GJ; Clift MJ; Doak SH
  • Conference publication: TOXICOLOGY LETTERS. 2021;350:S9-S10
    Nymark P; Hongisto V; Kohonen P; Jeliazkova N; Karlsson HL; Grafstrom R
  • Conference publication: TOXICOLOGY LETTERS. 2021;350:S38
    Nymark P; Martens M; Willighagen E; Hongisto V; Kohonen P; Grafstrom RC; Beronius A; Halappanavar S
  • Preprint: CHEMRXIV. 2021
    van Rijn J; Afantitis A; Culha M; Dusinska M; Exner T; Jeliazkova N; Longhin EM; Lynch I; Melagraki G; Nymark P; Papadiamantis AG; Winkler DA; Yilmaz H; Willighagen E
  • Preprint: CHEMRXIV. 2021
    van Rijn J; Afantitis A; Culha M; Dusinska M; Exner T; Jeliazkova N; Longhin EM; Lynch I; Melagraki G; Nymark P; Papadiamantis AG; Winkler DA; Yilmaz H; Willighagen E
  • Review: SMALL. 2021;17(15):e2006055
    Llewellyn SV; Niemeyer M; Nymark P; Mone MJ; van de Water B; Conway GE; Jenkins GJS; Doak SH
  • Review: SMALL. 2021;17(15):e2007628
    Halappanavar S; Nymark P; Krug HF; Clift MJD; Rothen-Rutishauser B; Vogel U
  • Preprint: PREPRINTS.ORG. 2021
    Nymark P; Sachana M; Leite SB; Sund J; Krebs CE; Sullivan K; Edwards S; Viviani L; Willett K; Landesmann B; Wittwehr C
  • Editorial comment: F1000RESEARCH. 2021;10:1196
    Lynch I; Nymark P; Doganis P; Gulumian M; Yoon T-H; Martinez DST; Afantitis A
  • Corrigendum: NANOIMPACT. 2021;21
    Giusti A; Atluri R; Tsekovska R; Gajewicz A; Apostolova MD; Battistelli CL; Bleeker EAJ; Bossa C; Bouillard J; Dusinska M; Gomez-Fernandez P; Grafstrom R; Gromelski M; Handzhiyski Y; Jacobsen NR; Jantunen P; Jensen KA; Mech A; Maria Navas J; Nymark P; Oomen AG; Puzyn T; Rasmussen K; Riebeling C; Rodriguez-Llopis I; Sabella S; Sintes JR; Suarez-Merino B; Tanasescu S; Wallin H; Haase A
  • Editorial comment: ALTEX. 2021;38(2):351-357
    Wittwehr C; Amorim MJ; Clerbaux L-A; Krebs C; Landesmann B; Macmillan DS; Nymark P; Ram R; Garcia-Reyero N; Sachana M; Sullivan K; Sund J; Willett C
  • Review: PARTICLE AND FIBRE TOXICOLOGY. 2020;17(1):16
    Halappanavar S; van den Brule S; Nymark P; Gate L; Seidel C; Valentino S; Zhernovkov V; Danielsen PH; De Vizcaya A; Wolff H; Stoger T; Boyadziev A; Poulsen SS; Sorli JB; Vogel U
  • Review: NANOMATERIALS. 2020;10(5):E903-903
    Federico A; Serra A; Ha MK; Kohonen P; Choi J-S; Liampa I; Nymark P; Sanabria N; Cattelani L; Fratello M; Kinaret PAS; Jagiello K; Puzyn T; Melagraki G; Gulumian M; Afantitis A; Sarimveis H; Yoon T-H; Grafstrom R; Greco D
  • Show more

News from KI

Events from KI